Experimental research shows cysteinyl leukotrienes enhance allergen absorption, triggering anaphylaxis in mice, suggesting new treatment strategies.
Food-specific immunoglobulin E (IgE) triggers life-threatening anaphylaxis; however, for unclear reasons, some people with food-specific IgE are asymptomatic upon allergen consumption. We studied strains of mice with different sensitivities to anaphylaxis when orally challenged with allergen to identify possible causes. In resistant C57BL/6 mice, intestinal goblet cells transported less food allergen than did anaphylaxis-susceptible strains, even before allergic sensitization. In a forward genetic screen, resistance was correlated with dipeptidase 1 ( Dpep1 ) variants. DPEP1 is expressed in intestinal epithelium and catabolizes leukotriene D 4 (LTD 4 ). Blocking DPEP1 with cilastatin, deleting Dpep1 , or administering LTD 4 orally enhanced allergen transport in resistant mice. Conversely, pretreatment of susceptible mice with a synthesis inhibitor, zileuton, abrogated allergen absorption and oral anaphylaxis, indicating that this could be an approach to treating food allergy.
No takes yet. Share an insight, caveat, or question.
Hoyt et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: